Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of… Jun 27, 2022
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for the Treatment of Major… May 31, 2022
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business Highlights Sep 15, 2021
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology Aug 3, 2021
